There are 2 subgroups of NA inhibitors that have been approved by regulatory authorities in the US and Europe, Zanamivir and Oseltamivir.  Both are for the treatment and prevention of influenza.  Furthermore, Peramivir and Laninamivir have been approved by regulatory authorities in some parts of Asia.